Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
21.00    0.00 (0.00%)
Bid:
20.90
Ask:
21.90
Spread: 1.00 (4.785%)
Market Cap: €116.56b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

BBVA Dividend option

11 Apr 2012 18:22

RNS Number : 1696B
Banco Bilbao Vizcaya Argentaria SA
11 April 2012
 

 

 

Banco Bilbao Vizcaya Argentaria, S.A.(BBVA), in compliance with the Securities Market legislation, hereby communicates the following:

 

 

 

RELEVANT EVENT

In connection with the relevant event of March 28, 2012 (Filing No. 160866), BBVA hereby submits, for purposes of articles 26.1.e) and 41.1.d) of Royal Decree 1310/2005 of November 4, this supplementary document to the Information Document relating to the free-of-charge capital increase by which a system of flexible shareholder remuneration called "Dividend Option" is to be instrumented.

 

Madrid, April 11, 2012

 

supplementary document to the Information Document

 

CAPITAL INCREASE CHARGED TO VOLUNTARY RESERVES

 

BANCO BILBAO VIZCAYA ARGENTARIA, S.A.

 

 

April 11, 2012

 

  

THIS DOCUMENT HAS BEEN PREPARED IN ACCORDANCE WITH ARTICLES 26.1.E) AND 41.1.D) OF ROYAL DECREE 1310/2005 OF NOVEMBER 4.

 

Disclaimer: The English version is a free translation of the original in Spanish for information purposes only. In the event of discrepancy, the Spanish original will prevail

1. INTRODUCTION

This document (the "Supplementary Document") has been issued to supplement the information provided in the information document relating to the capital increase charged to voluntary reserves approved by the ordinary general shareholders' meeting of Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA" or the "Bank") held on March 16, 2012, under item 4.1 of the fourth point of its agenda (the "Capital Increase"), which was published by means of a relevant event on March 28, 2012, with filing number 160866 (the "Information Document"). Capitalized terms used but not defined herein have the meanings assigned to them in the Information Document.

This Supplementary Document sets forth below the information relating to the Capital Increase which was outstanding at the date of publication of the Information Document and, in particular, the number of shares to be issued (with the possibility of incomplete subscription being expressly provided for), the number of free allotment rights necessary to receive one new share ("NAR") and the price at which BBVA has undertaken to acquire free allotment rights from shareholders, in the terms set forth in the Information Document.

This Supplementary Document and the Information Document have been issued in accordance with articles 26.1.e) and 41.1.d) of Royal Decree 1310/2005, of November 4, which provide that the preparation and publication of a prospectus related to the issuance and admission to listing of the shares issued as a consequence of the execution of the Capital Increase will not be necessary "provided that a document is made available containing information on the number and nature of the shares and the reasons for and details of the offer". This Supplementary Document together with the Information Document constitute such document. This Supplementary Document and the Information Document are available on the CNMV's website (www.cnmv.es) and the Bank's website (www.bbva.com).

2. SUPPLEMENTARY INFORMATION TO THE INFORMATION DOCUMENT

The Executive Committee of BBVA, in its meeting held on April 11, 2012, has agreed to implement the Capital Increase in accordance with the terms approved by the ordinary general shareholders' meeting of BBVA held on March 16, 2012, under item 4.1 of the fourth point of its agenda, and by the Board of Directors of BBVA, in its meeting held on March 28, 2012. In accordance with the formulas approved by these bodies, the Executive Committee has approved the following parameters concerning the Capital Increase:

(i) The number of new shares to be issued as a consequence of the execution of the Capital Increase ("New Shares") will be 107,682,603 New Shares. Accordingly, the aggregate nominal value of the Capital Increase will be €52,764,475.47, which is the product of multiplying the number of New Shares 107,682,603 by the nominal value of €0.49 per New Share.

The number of New Shares to be issued is the result of applying the formulas provided for in the applicable resolution adopted by the ordinary general shareholders' meeting of BBVA held on March 16, 2012, under item 4.1 of the fourth point of its agenda, and by the Board of Directors of BBVA, in its meeting held on March 28, 2012, considering that the number of old shares outstanding is 5,061,082,3781 ("NOS"), that the reference market value is €615,000,000 ("RMV") and that the reference price is €5.677 ("reference price" or "RP").2 On this basis:

(a) The number of rights to be assigned ("rights to be assigned" or "NAR") is 47, in accordance with the formula in the shareholders' and board's resolutions (rounded up to the nearest whole number):

NAR = RP x NOS / RMV

which, as applied, results in:

NAR = €5.677 x 5,061,082,378 / 615,000,000 = 47

(b) The number of New Shares to be issued is 107,682,603 New Shares, in accordance with the formula in the shareholders' and board's resolutions (rounded down to the nearest whole number):

New Shares = NOS / NAR

which, as applied, results in:

New Shares = 5,061,082,378 / 47 = 107,682,603

Notwithstanding this, the number of New Shares actually issued and, as a result, the nominal value of the Capital Increase may be less than the foregoing depending on the number of rights acquired by the Bank pursuant to its undertaking to acquire the free allotment rights for a fixed price. BBVA will waive the free allotment rights acquired pursuant to such undertaking. As a result, only those shares corresponding to the free allotment rights which have not been acquired by BBVA pursuant to its undertaking will be issued.

The New Shares will be issued at their nominal value of forty-nine euro cents (€0.49) per New Share, without issuance premium.

1 This amount reflects the voluntary conversion into shares, at the option of the holders, of BBVA’s mandatory convertible subordinated bonds issued in December 2011, after which the number of old shares outstanding is 5,061,082,378.
2 The Reference Price corresponds to the arithmetic mean of the weighted average prices of BBVA’s shares on the Spanish Stock Exchanges (Mercado Continuo) over the five trading sessions immediately prior to April 11, 2012, the date that BBVA’s Executive Committee resolved to effect the Capital Increase, rounded to the nearest thousandth of a euro and, in the case of a half of a thousandth of a euro, the immediately higher thousandth of a euro. 

(ii) The number of rights necessary to receive one New Share is 47.

BBVA shareholders who appear as such in the book-entry registries of Sociedad de Gestión de los Sistemas de Registro, Compensación y Liquidación de Valores, S.A. ("Iberclear") at 23:59 Madrid time on the day of publication of the announcement of the Capital Increase in the Official Bulletin of the Commercial Registry ("Boletín Oficial del Registro Mercantil") (envisaged for April 13, 2012) will receive a free allotment right for each BBVA share held. Consequently, such shareholders will have a right to receive one New Share for each 47 shares held by them on such date.

To ensure that all free allotment rights are effectively exercisable and that the number of New Shares to be issued is a whole number, BBVA has renounced 37 rights corresponding to 37 shares held as treasury shares.

(iii) The fixed purchase price of each freely allotted right assumed by BBVA is €0.118 per right, in accordance with the formula approved by the ordinary general shareholders' meeting of BBVA held on March 16, 2012, under item 4.1 of the fourth point of its agenda, and by the Board of Directors of BBVA, in its meeting held on March 28, 2012 (rounded to the nearest thousandth of a euro and, in the case of a half of a thousandth of a euro, the immediately higher thousandth of a euro):

Purchase price = RP / (NAR +1)

which, as applied, results in:

Purchase price = 5.677 / (47 + 1) = €0.118

Accordingly, shareholders who wish to receive a dividend in cash can sell their rights to BBVA at a gross fixed price of €0.118 per right.

As indicated in the Information Document, this option is granted exclusively to the shareholders of BBVA who have such condition at the time the free allotment rights are allocated and only in connection with the free allotment rights which are originally allocated to them at such time; accordingly, this option will not be available in respect of any free allotment right acquired through a market purchase.

BBVA's undertaking to acquire rights at this fixed price will be in effect from the first trading day of the rights, which is expected to take place on April 16, 2012 through April 25, 2012, both inclusive.3

3 The options, terms and procedures indicated in this information document may not be the same in respect of BBVA shares listed outside Spain, including in the form of BBVA ADSs.

* * *

Banco Bilbao Vizcaya Argentaria, S.A.

P.p.

Erik Schotkamp

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIBMRTMBBBBTT
Date   Source Headline
12th Feb 20147:00 amRNSPerpetual contingent convertible securities
7th Feb 20144:54 pmRNSRemuneration policy of the BBVA board of directors
7th Feb 20144:49 pmRNS2013 Annual Corporate Governance Report
7th Feb 20144:29 pmRNSProposed resolutions and the director's report
31st Jan 20148:55 amRNSResults year 2013: Analysts presentation
31st Jan 20147:44 amRNSPress release and group information 2013
31st Jan 20147:00 amRNSAGM Statement
27th Jan 20145:11 pmRNSResults of BBVA for 4Q 2013 will be presented
27th Jan 20147:00 amRNSAccount reclassification
20th Dec 20137:00 amRNSSale in PANAMA
20th Dec 20137:00 amRNSCORPBANCA
5th Nov 201311:05 amRNSDividend option: Capital increase
25th Oct 20139:03 amRNSAnalysts presentation: 3rd Quarter Results
25th Oct 20137:22 amRNS3rd Quarter: Press release and group information
21st Oct 20135:39 pmRNSBBVA results for 3Q 2013 will be presented
21st Oct 20131:07 pmRNSCNCB's PARTIAL SALE
17th Oct 20139:03 amRNSCNCB's PARTIAL SALE (Information)
17th Oct 20137:01 amRNSCNCB's PARTIAL SALE
14th Oct 20136:10 pmRNSDividend option
2nd Oct 20137:51 amRNSBBVA completes the sale of AFP Provida- Chile
25th Sep 20136:17 pmRNSAppointment in the executive committee
25th Sep 20135:04 pmRNSDividend option
13th Sep 20135:29 pmRNS"Dividend Option"
12th Sep 20139:05 amRNSInvestment plan for South America in 2013 - 2016
26th Jul 20135:13 pmRNSPresentation of the results for 2Q13
22nd Jul 20137:00 amRNSAgreement for the sale of BBVA Panama
16th Jul 20134:24 pmRNSApplication for admission new ordinary shares
4th Jul 201311:20 amRNSOffering Circular - Replacement
3rd Jul 20135:40 pmRNSConvertible Bonds
3rd Jul 20131:06 pmRNSSupplement to the Offering Circular
28th Jun 20136:26 pmRNSConvertible Bonds
24th Jun 20135:09 pmRNSFirst interim dividend against 2013 results
21st Jun 20137:51 amRNSConvertible bonds
12th Jun 20136:20 pmRNSClauses limiting the interest rate
6th Jun 20135:43 pmRNSStabilisation Notice
30th May 20137:00 amRNSAppointment new executive director of BBVA
24th May 20137:00 amRNSPayment of interests
23rd May 20136:06 pmRNSUnnim Banc S.A., merger by absorption
21st May 20135:21 pmRNSCONVERTIBLE BONDS
14th May 20133:59 pmRNSCapital increase
30th Apr 20135:57 pmRNSIssue securities
29th Apr 20133:20 pmRNSStabilisation Notice
26th Apr 20132:40 pmRNSPublication of Financial Statements
26th Apr 20138:52 amRNS1st Quarter Results: Analysts presentation
26th Apr 20137:19 amRNS1st Quarter: Press release and group information
24th Apr 20137:00 amRNSSale in Peru: AFP Horizonte S.A.
22nd Apr 20136:17 pmRNSDividend option: trading period has ended today
22nd Apr 20136:04 pmRNSBBVA Results for 1Q 2013 will be presented
22nd Apr 20137:00 amRNSChanges in the structure of the information
19th Apr 20137:00 amRNSSale in Colombia

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.